The Estée Lauder Companies Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

Wall Street Lifts Estee Lauder Price Targets to $85: Is the China Comeback Finally Real?

AI-generated analysis

📈 Estée Lauder delivered a 40% Q3 earnings beat with revenue reaching $3.71 billion, a 5% year-over-year increase.

🇨🇳 Mainland China revenue climbed 11%, marking the third consecutive quarter of strong performance in that market.

💰 Adjusted operating margin expanded significantly by 360 basis points to reach 15% for the first time in four years.

📉 Canaccord and Wells Fargo both raised their price targets on Estée Lauder stock to $85 following the strong results.

⚖️ Despite the price target hikes, both firms maintained neutral ratings (Hold/Equal Weight), signaling cautious sentiment.

🧪 Fragrance categories led growth with a 13% increase, while skin care, makeup, and hair care all posted gains.

📈 Management raised FY2026 adjusted EPS guidance to between $2.35 and $2.45 and previewed FY2027 margins near 13%.

🗣️ CEO Stéphane de La Faverie declared fiscal 2026 the pivotal year for the company's recovery and turnaround plan.

🔒 A potential transaction with PUIG remains an open variable that could impact future valuations and strategy.

📊 The stock trades at a forward P/E of 26x and is currently down 21% year-to-date but up 20% over the past month.

🐻 Bears warn of uneven travel retail recovery, pressure from indie cosmetics rivals, and elevated FY2027 expectations.

⚠️ The broader analyst consensus target sits at $95.59, though a significant mix of 13 analysts still rate the stock as Hold.

👀 Prudent investors are advised to monitor Q4 results, China sell-through metrics, and any news regarding the PUIG deal.

Bullish Signals
  • Estée Lauder delivered a significant 40% Q3 earnings beat, demonstrating strong financial performance beyond analyst expectations.
  • Revenue reached $3.71 billion with a 5% year-over-year increase, indicating robust top-line growth.
  • Mainland China revenue climbed 11% for the third consecutive quarter, confirming a sustained turnaround in that key market.
  • Adjusted operating margins expanded 360 basis points to 15%, marking margin expansion for the first time in four years.
  • Two major Wall Street firms, Canaccord and Wells Fargo, lifted their price targets to $85, signaling increased confidence in the company's operational progress.
  • Management raised full-year guidance, projecting fiscal 2026 adjusted EPS between $2.35 and $2.45 with a clearer path for FY2027.
  • Fragrance sales led growth with a strong 13% increase, while skin care, makeup, and hair care categories all posted upward movement.
  • CEO Stéphane de La Faverie identified fiscal 2026 as the pivotal year for recovery, aligning with management's strategic timeline.
  • The stock recently rallied up 20% over the past month despite trading down year-to-date, showing positive market sentiment.
Risk Factors
  • Both major Wall Street firms (Canaccord and Wells Fargo) maintained neutral 'Hold' or 'Equal Weight' ratings despite raising price targets, indicating lingering caution on valuation.
  • The company still trades well below its 52-week high of $121.25 and is down 21% year-to-date, reflecting a significant discount from recent peaks.
  • Analyst consensus remains tilted toward 'Hold' ratings, suggesting the stock has not yet achieved full re-rating in Wall Street's eyes.
  • Wells Fargo explicitly flagged the potential PUIG transaction as an open variable that adds risk and raises valuation bar uncertainty.
  • Travel retail recovery is described as uneven, which poses a headwind for a significant portion of Estée Lauder's sales channels.
  • Independent cosmetics rivals continue to pressure the low end of the market, threatening margin expansion in value segments.
  • FY2027 expectations have become elevated due to recent guidance changes, increasing the risk that future results may miss these higher targets.
Full Analysis
Estée Lauder Companies (NYSE: EL) delivered a robust Q3 earnings report that significantly exceeded Wall Street expectations, driving a notable shift in analyst sentiment and price targets. The company reported adjusted earnings per share of $0.91 against a consensus expectation, with revenue reaching $3.71 billion, a 5% year-over-year increase. This performance was heavily bolstered by a resurgence in Mainland China, where revenue grew 11%, marking the third consecutive quarter of double-digit growth in that key market. Additionally, adjusted operating margins expanded significantly by 360 basis points to reach 15%, validating the company's Profit Recovery and Growth Plan after four years of margin contraction. Following these results, two major Wall Street firms updated their valuations for EL stock. Canaccord Genuity raised its price target from $80 to $85 while maintaining a Hold rating, citing operational progress across all product categories and successful cost-cutting initiatives. Wells Fargo similarly lifted its target from $75 to $85 with an Equal Weight rating, emphasizing the strength of Q4 organic sales guidance and the firmness of fiscal 2027 margin targets. Notably, Canaccord analyst Mike Hickey specifically highlighted China share gains and growth across fragrances, skin care, makeup, and hair care as primary drivers for the revision. The core narrative driving the price target increase is the company's strategic turnaround, with management positioning fiscal 2026 as the pivotal year for full recovery under CEO Stéphane de La Faverie. The revised guidance for fiscal 2026 raises adjusted EPS expectations to between $2.35 and $2.45, with a longer-term view toward approaching 13% operating margins in 2027. Despite the bullish data, both firms maintain neutral ratings, suggesting that while operational execution is improving, broader valuation concerns regarding travel retail recovery, independent cosmetics competition, and elevated expectations for 2027 keep the stock from a more enthusiastic re-rating. Estée Lauder shares are currently trading at approximately $83, reflecting a 21% decline year-to-date but a 20% rebound over the past month, with a forward price-to-earnings ratio of 26x. The consensus analyst target remains higher at $95.59, indicating further upside potential if the trajectory holds. Prudent investors are advised to watch the upcoming Q4 FY2026 results for continued China sell-through, organic sales delivery, and any developments regarding a potential transaction with PUIG, which Wells Fargo flagged as an open variable affecting valuation. The market view remains cautiously optimistic about the turnaround narrative taking shape while acknowledging the elevated bar set by recent earnings beats.